Table 2.

Assessment of Tumor Response Between Two Treatment Groups

Response	DEB-TACE Group (n=46)	C-TACE Group (n=52)	P value
CR	7 (15.2%)	2 (3.9%)	0.111
PR	28 (60.9%)	19 (36.5%)	0.016
SD	7 (15.2%)	18 (34.6%)	0.028
PD	4 (8.7%)	13 (25.0%)	0.033
ORR	35 (76.1%)	21 (40.4%)	<0.001
DCR	42 (91.3%)	39 (75.0%)	0.033

Abbreviations: DEB-TACE, drug-eluting beads transarterial chemoembolization; C-TACE, conventional transarterial chemoembolization; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate.